News
The Ultimate Pain Relief Guide: Proven Tips to Manage Discomfort Naturally
Pain is something that we all go through somehow or some time. There is acute pain, like a sprain to your ankle, or chronic pain, like back pain. When pain is present, it often leads individuals to instinctively establish...
News
Medical Negligence in 2025: Pharma’s Role in Ensuring Patient Safety
In the ever-evolving world of healthcare, the role of pharmaceutical companies in ensuring patient safety has never been more significant. As we step into 2025, the landscape of medical negligence is undergoing critical changes. If you are seeking professional...
News
When Pharma Meets the Underworld: How Legitimate Drug Supply Chains and Illicit Drug Markets Collide
In today's global landscape, the intersection between legitimate pharmaceutical supply chains and illicit drug markets presents significant challenges. This confluence not only impacts public health but also raises legal and ethical concerns. If you are concerned about the legal...
News
Pharma’s Philanthropic Scrutiny: Navigating Charity Commission Investigations in Healthcare Giving
In the healthcare sector, the intersection of pharmaceutical companies and charitable organisations plays a pivotal role in enhancing global health outcomes. However, when these partnerships are under scrutiny, particularly by regulatory bodies like the Charity Commission, it becomes essential...
News
Role of Combination Products is on the Rise in Biopharma
In the dynamic world of today, role of combination products happens to be emerging as catalysts when it comes to transformative healthcare solutions. Defined widely as therapeutics or even diagnostic products integrating drugs and medical devices as well as...
News
Buyout of SpringWorks Brings Back Merck KGaA in the M&A Game
Merck KGaA’s long-standing courtship of SpringWorks Therapeutics has finally come to a realization as the German drugmaker has purchased the Connecticut biopharma for an equity valuation of $3.9 billion, the company recently said.
The deal, which amounts to $47 per...
News
Roche Looks to Expand its Drug Production in the US
Roche is planning to expand its drug production in the US and has announced a pledge to spend $50 billion in the next five years on new as well as existing manufacturing facilities across several states.
This investment promise is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.